Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2024

  1. Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease

    ERJ Open Research, Vol. 10, Núm. 4

2023

  1. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7